Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes

…, J Lin, K Mortimer, PM Pitrez, A Sheikh… - American journal of …, 2022 - atsjournals.org
The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually
updated evidence-based strategy for asthma management and prevention, which can be …

[HTML][HTML] Global and regional estimates of COPD prevalence: Systematic review and meta–analysis

…, D Sridhar, H Campbell, KY Chan, A Sheikh… - Journal of global …, 2015 - ncbi.nlm.nih.gov
Background The burden of chronic obstructive pulmonary disease (COPD) across many
world regions is high. We aim to estimate COPD prevalence and number of disease cases for …

Is the prevalence of asthma declining? Systematic review of epidemiological studies

C Anandan, U Nurmatov, OCP Van Schayck, A Sheikh - Allergy, 2010 - Wiley Online Library
To cite this article: Anandan C, Nurmatov U, van Schayck OCP, Sheikh A. Is the prevalence
of asthma declining? Systematic review of epidemiological studies. Allergy 2010; 65: 152–…

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

…, P Schmid-Grendelmeier, A Sheikh… - Journal of Allergy and …, 2017 - Elsevier
Background Allergic rhinitis (AR) affects 10% to 40% of the population. It reduces quality of
life and school and work performance and is a frequent reason for office visits in general …

[HTML][HTML] Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an …

…, A Safa, S Sehdev, T Sevenoaks, D Shah, A Sheikh… - The Lancet, 2023 - thelancet.com
Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …

Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C …

…, MG Pritchard, CD Russell, CA Shaw, A Sheikh… - bmj, 2020 - bmj.com
Objective To develop and validate a pragmatic risk score to predict mortality in patients admitted
to hospital with coronavirus disease 2019 (covid-19). Design Prospective observational …

[HTML][HTML] Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection

…, CAC Coupland, KM Channon, NL Mills, A Sheikh… - Nature medicine, 2022 - nature.com
Although myocarditis and pericarditis were not observed as adverse events in coronavirus
disease 2019 (COVID-19) vaccine trials, there have been numerous reports of suspected …

[HTML][HTML] Sofosbuvir for previously untreated chronic hepatitis C infection

…, JG McHutchison, AM Sheikh… - … England Journal of …, 2013 - Mass Medical Soc
Background In phase 2 trials, the nucleotide polymerase inhibitor sofosbuvir was effective in
previously untreated patients with chronic hepatitis C virus (HCV) genotype 1, 2, or 3 …

EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy

…, S Panesar, D De Silva, K Soares‐Weiser, A Sheikh… - Allergy, 2014 - Wiley Online Library
Food allergy can result in considerable morbidity, impact negatively on quality of life, and
prove costly in terms of medical care. These guidelines have been prepared by the European …

Illness trajectories and palliative care

SA Murray, M Kendall, K Boyd, A Sheikh - Bmj, 2005 - bmj.com
Methods We searched our own database of papers, conducted a Medline search, and
approached experts for additional published references (further details available from SAM). We …